The US Food and Drug Administration has started a new comment period on its bioterrorism regulations – designed to safeguard the national food supply – which will have a significant impact on companies importing pharmaceutical excipients into the US, reports Phil Taylor. The US recently implemented two pieces of legislation – currently at the interim final rule stage – designed to safeguard the country’s food supply against bioterrorism. The first requires all food facilities to register with the FDA, while the second requires prior notice to US customs of any imported food shipments. Full Story
About OODA Analyst
OODA is comprised of a unique team of international experts capable of providing advanced intelligence and analysis, strategy and planning support, risk and threat management, training, decision support, crisis response, and security services to global corporations and governments.